Our Programs
We focus our resources on finding cures for diseases we fear the most - loss of mind and loss of sight.
Our Programs
BrightFocus Foundation is at the forefront of brain and eye health, advancing early-stage, investigator-initiated research around the world. Our programs are designed to provide initial funding for highly innovative experimental research and curative ideas for Alzheimer's disease, macular degeneration, and glaucoma.
Alzheimer's Disease Research
The Alzheimer’s Disease Research (ADR) program has funded nearly $60 million in research grants in the past five years alone and currently supports 167 active scientific projects worldwide in fields ranging from molecular biology to genetics to epidemiology.
Through our grants, scientists around the world have developed and tested thousands of hypotheses about how the disease destroys brain function over time. As part of this, they are investigating hundreds of ideas to diagnose, treat, cure, and prevent AD and related dementias.
Macular Degeneration Research
The Macular Degeneration Research (MDR) program has funded nearly $22 million in research grants in the past five years alone and currently supports 58 active scientific research projects worldwide.
Through our grants, scientists around the world have developed and tested hundreds of hypotheses about how the disease causes vision loss and blindness. As part of this, they are investigating dozens of ideas to prevent, treat and cure macular degeneration.
National Glaucoma Research
The National Glaucoma Research (NGR) program has funded nearly $16 million in research grants in the past five years alone and currently supports 62 active scientific research projects worldwide.
Through our grants, scientists around the world have developed and tested hundreds of hypotheses about how the disease destroys the optic nerve and results in vision loss and blindness. As part of this, they are investigating dozens of ideas to prevent, treat, and cure glaucoma.
Donate to Cure Diseases of Mind and Sight
Support groundbreaking research worldwide to end Alzheimer’s disease, age-related macular degeneration, and glaucoma.